☰

Tactica Pharmaceuticals S.A.

Recovering margin at the Gliwice plant

Industry
Pharmaceuticals (Generic and Sterile Manufacturing)
Headquarters
Gliwice, Poland
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Tactica Pharmaceuticals S.A.'s published strategy and is not endorsed by, or produced in cooperation with, Tactica Pharmaceuticals S.A.. Company website

Strategic priorities

Tactica Pharmaceuticals S.A. is a Polish pharmaceutical manufacturer operating the Gliwice plant with over 100M PLN in revenue. The company is pursuing margin recovery after experiencing a 4.34% net profit margin decline, using Industry 4.0 retrofitting and EU STEP/FENG grant funding to modernise production infrastructure. Key strategic initiatives include deploying real-time OEE tracking across multi-product lines, building an Industrial Data Platform to bridge the Krakow-Gliwice data gap, and achieving GMP/ALCOA+ compliance automation to eliminate recall risk and quality debt.

The defining challenge is production visibility fragmentation. Tactica operates multi-product lines with equipment that was not designed for digital connectivity, creating a production monitoring environment where OEE is calculated retrospectively rather than known in real time. The Krakow analytical centre and Gliwice manufacturing plant operate as separate information environments, preventing the integrated analysis that would identify performance improvement opportunities. Without real-time visibility, the production team manages the plant from yesterday's numbers rather than today's.

On the quality side, ALCOA+ compliance requires systematic documentation that grows with production volume. Manual compliance processes create recall risk and quality debt that erodes the margin recovery that the turnaround programme is intended to achieve.

Challenges we see

  • Digital Manufacturing

    OEE calculation latency preventing real-time production decision-making

    Tactica operates multi-product lines with equipment that was not designed for digital connectivity. OEE is calculated retrospectively from shift reports rather than known in real time from the shop floor, creating a response latency to production events that optimises yesterday rather than today.

    Where OEE is calculated from shift reports, the production manager manages the plant from yesterday's performance. Real-time OEE tracking means the production decisions are based on today's performance, not last shift's.

  • Digital Integration

    Krakow-Gliwice data gap preventing cross-site operational analytics

    The Krakow analytical centre and Gliwice manufacturing plant operate as separate information environments. The data generated by the analytical centre cannot be connected to production data from Gliwice without manual data transfer, preventing the integrated analysis that would improve both sites.

    Where Krakow and Gliwice operate as separate information environments, the analytical insights from Krakow cannot inform manufacturing decisions at Gliwice. A unified data platform means the full picture is visible, not just half of it.

  • Compliance Regulatory

    Manual ALCOA+ compliance creating recall risk and quality debt

    ALCOA+ compliance requires systematic documentation that grows with production volume. Manual compliance processes create recall risk and accumulate quality debt that erodes the margin recovery programme. The EU STEP/FENG grant funding provides the investment opportunity to address this systematically.

    Where ALCOA+ compliance is manual, the documentation quality degrades as production volume increases. Automated compliance means the documentation quality is independent of production volume.

  • Operations Bioprocess

    No PAT creating batch-to-batch variability at multi-product lines

    Multi-product lines produce pharmaceutical products with batch-to-batch quality variability that cannot be identified in real time without PAT. The absence of real-time quality monitoring means deviations are discovered at end-of-batch QC rather than corrected during the batch.

    Where PAT is absent, the batch quality is unknown until after the batch is complete. PAT deployment means the batch quality is known during the batch, enabling in-process corrections.

  • ESG Operations

    No systematic energy monitoring for ESG compliance and cost reduction

    Energy costs are a significant component of pharmaceutical manufacturing economics, but no systematic energy monitoring exists at the Gliwice plant. Reduction opportunities are identified by intuition rather than by data.

    Where energy monitoring is absent, the reduction opportunities are invisible. Digital energy monitoring means the reduction opportunities are quantified and trackable.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Real-time OEE tracking across Tactica multi-product manufacturing lines

    OEE is calculated retrospectively from shift reports, creating response latency that optimises yesterday's performance rather than today's. The production team cannot make real-time decisions because the data is not available in real time.

    Deploy real-time OEE tracking across all Tactica multi-product lines, providing the production team with live visibility into OEE components — availability, performance, quality — and enabling immediate response to production events.

    • Tactica operational assessment, 2025

  2. Unified Industrial Data Platform bridging Krakow analytical centre and Gliwice plant

    The Krakow analytical centre and Gliwice manufacturing plant operate as separate information environments. Analytical insights cannot inform manufacturing decisions without manual data transfer that introduces latency and error risk.

    Build a unified Industrial Data Platform that bridges the Krakow-Gliwice data gap, connecting analytical data with manufacturing data to enable the integrated analysis that improves both sites.

    • Tactica data infrastructure assessment, 2025

  3. Automated ALCOA+ compliance documentation for GMP manufacturing

    Manual ALCOA+ compliance documentation creates recall risk and accumulates quality debt. As production volume increases, the documentation burden grows faster than the quality team's capacity.

    Implement automated ALCOA+ compliance documentation that generates GMP-compliant records automatically as manufacturing progresses, eliminating recall risk and quality debt while freeing quality team capacity for value-added activities.

    • Tactica quality operations assessment, 2025

  4. PAT deployment for real-time batch quality at multi-product lines

    Batch-to-batch quality variability cannot be identified in real time without PAT. Deviations are discovered at end-of-batch QC rather than corrected during the batch, creating waste and delay.

    Deploy PAT at Tactica's multi-product lines, providing real-time quality monitoring that enables in-process corrections and reduces batch-to-batch variability.

    • Tactica PAT readiness assessment, 2025

  5. Digital energy monitoring for ESG compliance and cost reduction

    No systematic energy monitoring exists at the Gliwice plant. Energy reduction opportunities are identified by intuition rather than by data, and ESG reporting requires data that manual collection cannot provide efficiently.

    Deploy digital energy monitoring at the Gliwice plant, providing the energy consumption visibility required for both cost reduction and ESG compliance reporting.

    • Tactica energy efficiency assessment, 2025

What we'd propose

  • Digital CDMO

    Real-time OEE tracking platform for Tactica multi-product manufacturing

    We deploy a real-time OEE tracking platform for Tactica's Gliwice multi-product lines that provides the production team with live visibility into OEE components — availability, performance, quality — enabling immediate response to production events and transforming manufacturing from reactive to proactive.

    • Edge connectivity for legacy equipment

      Real-time data extracted from equipment never designed for digital connectivity

      Deploy edge connectivity solutions that extract real-time data from legacy manufacturing equipment — cycle counts, rejection rates, changeovers — providing the data foundation for real-time OEE calculation without requiring equipment replacement.

    • Real-time OEE dashboard for production team

      Live OEE visible on the shop floor and in the control room

      Deliver real-time OEE dashboards that present availability, performance and quality metrics to the production team on the shop floor and in the control room, enabling immediate response to events that are dragging down OEE.

    • Loss analysis and root cause identification

      Big losses identified automatically with corrective action guidance

      Build loss analysis that identifies the biggest OEE losses — unplanned stops, speed losses, quality rejections — and provides root cause identification that enables targeted corrective actions.

    • OEE improved by enabling the production team to respond to events in real time rather than learning about them the next shift.
    • Losses identified and corrected faster by automated loss analysis that surfaces the biggest opportunities.
    • Production decisions based on real-time data rather than yesterday's shift reports.

    We've done this before

    See how we do Digital CDMO
  • Digital CDMO

    Unified Industrial Data Platform for Tactica Krakow-Gliwice operations

    We build a unified Industrial Data Platform for Tactica that bridges the Krakow analytical centre and Gliwice manufacturing plant, connecting analytical data with production data to enable the integrated cross-site analytics required for margin recovery.

    • Cross-site data integration pipeline

      Krakow and Gliwice data connected in one unified platform

      Build data integration pipelines that connect Krakow analytical centre data with Gliwice manufacturing data into a unified platform, eliminating the manual data transfer that currently prevents integrated cross-site analytics.

    • Cross-site operational analytics

      Analytical-insight and manufacturing-performance visible together

      Deliver cross-site operational analytics that combine analytical results from Krakow with production performance from Gliwice, enabling the integrated insights that improve both sites.

    • Data quality and governance framework

      Data standards established and enforced across both sites

      Implement data quality and governance that establishes consistent data standards across Krakow and Gliwice, ensuring that the integrated dataset meets the quality requirements for both operational and regulatory use.

    • Cross-site insights enabled by connecting Krakow analytical data with Gliwice production data.
    • Margin recovery supported by integrated analytics that identify improvement opportunities neither site could see alone.
    • Regulatory data quality improved by consistent standards across both sites.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    Automated ALCOA+ compliance documentation for Tactica GMP operations

    We implement automated ALCOA+ compliance documentation for Tactica's GMP manufacturing operations that generates compliance records automatically as production progresses, eliminating recall risk and quality debt while freeing quality team capacity for value-added activities.

    • Automated GMP record generation from production data

      GMP records assembled automatically as manufacturing progresses

      Build automated GMP record generation that captures production parameters, material inputs and quality test results from the manufacturing execution system, assembling ALCOA+-compliant GMP records without manual documentation.

    • Electronic batch record with audit trail

      Complete, attributable batch records with full audit trail

      Implement electronic batch records with complete audit trails that satisfy FDA 21 CFR Part 211 requirements, replacing paper-based batch records that are vulnerable to loss, damage and transcription errors.

    • Recall prevention and quality debt elimination

      ALCOA+ compliance eliminates the documentation basis for recalls

      Build recall prevention monitoring that uses the automated ALCOA+ documentation to identify documentation gaps before they become regulatory findings, systematically eliminating the quality debt that currently creates recall exposure.

    • Recall risk eliminated by ALCOA+-compliant documentation maintained continuously rather than assembled retrospectively.
    • Quality team capacity redirected from documentation assembly to value-added quality oversight.
    • EU STEP/FENG grant investment justified by demonstrable ALCOA+ compliance improvement.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    PAT deployment for Tactica multi-product line real-time quality monitoring

    We deploy PAT for Tactica's multi-product manufacturing lines, providing real-time quality monitoring that enables in-process corrections and reduces batch-to-batch variability, improving product quality consistency and reducing waste from out-of-specification batches.

    • Real-time quality sensor deployment

      Critical quality attributes monitored in real time during production

      Deploy real-time quality sensors that monitor critical quality attributes during production — assay, purity, dissolution — providing the PAT data that enables in-process corrections and real-time batch quality assessment.

    • In-process control and automated adjustments

      Quality deviations corrected during the batch, not after

      Build in-process control that uses PAT data to identify when process parameters are drifting toward quality limits, enabling automated or operator-initiated adjustments before the batch goes out of specification.

    • PAT-based batch release support

      Real-time quality data supports accelerated batch release decisions

      Implement PAT-based batch release support that uses real-time quality data to demonstrate batch quality continuously, supporting reduced end-of-batch QC requirements and accelerated release timelines.

    • Batch-to-batch variability reduced by in-process corrections that PAT data enables.
    • Out-of-specification waste reduced by early warning from real-time quality monitoring.
    • Batch release timeline shortened by PAT data that demonstrates quality continuously.

    We've done this before

    See how we do Digital CDMO
  • Enterprise AI

    Digital energy monitoring for Tactica ESG compliance and cost reduction

    We deploy digital energy monitoring for Tactica's Gliwice plant that provides real-time energy consumption visibility across all production lines, enabling quantified reduction opportunities and automated ESG reporting for EU STEP/FENG grant compliance.

    • Sub-metered energy monitoring across production lines

      Energy consumption visible by line, shift and product

      Deploy sub-metered energy monitoring across all Gliwice production lines, providing granular visibility into energy consumption by production line, shift and product that enables targeted reduction initiatives.

    • Energy efficiency benchmarking and anomaly detection

      Energy waste identified automatically, not by operator intuition

      Build energy efficiency benchmarking that compares energy consumption across identical production campaigns, automatically identifying anomalies that indicate waste or equipment issues requiring attention.

    • Automated ESG energy reporting

      EU STEP/FENG grant ESG reports generated automatically

      Implement automated ESG energy reporting that generates the energy consumption and reduction metrics required for EU STEP/FENG grant compliance reporting, reducing the manual reporting effort and ensuring accuracy.

    • Energy cost reduction opportunities identified through data rather than operator intuition.
    • EU STEP/FENG grant compliance demonstrated through automated ESG reporting.
    • Margin recovery supported by quantified energy cost reduction.

    We've done this before

    See how we do Enterprise AI

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Tactica Pharmaceuticals S.A.'s own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Real-Time OEE Visibility 15 → 85
OEE is calculated retrospectively from shift reports. No real-time OEE tracking is deployed. Production management is reactive rather than proactive.
Cross-Site Data Integration 15 → 80
Krakow analytical centre and Gliwice manufacturing operate as separate information environments. No unified Industrial Data Platform exists. Cross-site analytics require manual data transfer.
ALCOA+ Compliance Automation 20 → 80
ALCOA+ compliance documentation is manual. No automated compliance documentation is deployed. Quality debt accumulates with production volume. Recall risk is present.
PAT Deployment 15 → 75
No PAT is deployed at multi-product lines. Batch quality is unknown until end-of-batch QC. Batch-to-batch variability is not identified in real time.
Energy Monitoring 15 → 70
No systematic energy monitoring is deployed. Energy reduction opportunities are not systematically identified. ESG reporting depends on manual data collection.
Digital Operations Maturity 25 → 75
Gliwice plant has limited Industry 4.0 infrastructure. EU STEP/FENG grant funding creates the investment opportunity to accelerate digital transformation.

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Tactica Pharmaceuticals S.A., and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].